Caricamento...
New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones
Missense mutations in the lysosomal hydrolase β‐galactocerebrosidase (GALC) account for at least 40% of known cases of Krabbe disease (KD). Most of these missense mutations are predicted to disrupt the fold of the enzyme, preventing GALC in sufficient amounts from reaching its site of action in the...
Salvato in:
| Pubblicato in: | J Neurosci Res |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5031207/ https://ncbi.nlm.nih.gov/pubmed/27638604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jnr.23762 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|